Pregnancy
How Progyny is harnessing wearables to deliver data-driven care

As women face mounting barriers to essential reproductive care, Progyny is tackling health inequities head-on, harnessing wearable tech, and partnering with employers to make healthcare more accessible, chief operating officer Melissa Cummings tells Femtech World.
Many women and their families face barriers when it comes to accessing essential reproductive care. Financial and legislative restrictions often leave women facing high healthcare costs and experiencing poor clinical outcomes.
Founded in 2016, Progyny – a “global leader” in women’s health – recognises the urgent need to remove these barriers, providing personalised clinical solutions for women’s health and fertility-related issues, and is working with employers, patients and providers to improve access and reduce costs.
“Individuals today face an increasingly fragmented landscape when seeking healthcare, which leads to stressful and costly experiences,” Melissa Cummings, COO at Progyny, tells Femtech World.
“We are committed to streamlining access to essential care while reducing costs for everyone involved.”
Progyny solutions include clinical programming and coaching for fertility, one-on-one member support, personalised surrogacy and adoption coaching and support, a network of fertility specialists, along with integrated Rx and access to digital tools.
Supporting healthy families
With one in six families impacted by infertility, Progeny has developed a benefit model that ensures members have their care covered throughout their treatment, to help these families access the vital care they need.
Its support begins before a person is pregnant and continues throughout pregnancy to support positive outcomes and healthy families.
“We’ve been in the market for nearly a decade and have pioneered the delivery of fertility benefits for the nation’s leading employers,” says Cummings.
“We have since built that foundation to offer comprehensive support for women throughout all stages of life, including preconception, fertility and family building, pregnancy, postpartum, parenting, menopause and midlife.
“Our outcomes prove that comprehensive, inclusive, and intentionally-designed solutions simultaneously benefit employers, patients, and physicians.”
Driven by data
These services are now being integrated into wearable technologies to provide more personalised health support and health programmes for specific conditions that are contributing to life-changing outcomes for its members.
“This year, we’ve expanded our offerings through collaborations with Oura Ring, where we incorporate wearable data and insights into our care team decision-support process, as well as with Hinge Health/Origin to offer support for pelvic floor therapy,” says Cummings.
Progyny’s pelvic floor therapy support now provides access to digital care supported by physical therapists specialising in pelvic health and musculoskeletal care through Hinge Health, and access to Origin’s nationwide in-network pelvic floor physical therapy, both in-person and online, along with personalised care plans.
By incorporating this wearable data, Progyny can identify potential risks earlier and support health goals such as optimising conception attempts or making lifestyle changes.
Equally, with the Oura ring tracking key health metrics such as sleep patterns, cycle insights, cardiovascular health and stress levels, the use of this data helps to lay the groundwork for improved pregnancy and fertility outcomes.
The data can also be used to provide insights during perimenopause or menopause and help to guide lifestyle adjustments.
“Our data-driven model is the foundation to improve clinical outcomes through tracking treatment utilisation, clinical performance, and patient outcomes,” she continues.
“As a result, we have superior outcomes – including higher pregnancy rates, fewer miscarriages, and lower rates of multiple births.”
Bridging the gap
With 59 per cent of women missing work due to menopause symptoms, Progyny provides services that support employers to ensure benefit efficiency without compromising on employee care.
This support ensures equitable access to speciality care from Progyny’s network of leading specialists.
Cummings says: “We work with employers to save healthcare dollars by providing employees with a more comprehensive journey that leads to healthier employees and babies.
“For employees, we provide personalised support through our Progyny Care Advocates, access to top fertility clinics that we have thoroughly and rigorously vetted, and bundled benefits so they can make better healthcare decisions based on their needs, not their wallets.
“We support equitable access to care by bridging the gap between employers, patients, and providers. “
Growing demand for whole-person care
This year, the company has expanded its services through the acquisition of BenefitBump, a parental leave benefits navigation programme, along with launching further maternal health support with the addition of doula services.
“In the coming year, we’re focused on expanding our women’s health platform across the full spectrum: from preconception to menopause,” says Cummings.
“Employers see the impact – 40 per cent of new clients have adopted at least one of these newer services, and we’re just getting started.”
Progyny was recently recognised as Company of the Year at the Femtech World Awards, which Cummings says reflects a growing demand for inclusive, whole-person care.
Pregnancy
Women with pre-eclampsia at increased risk of chronic kidney disease, study finds

Women who develop pre-eclampsia face a higher risk of chronic kidney disease and high blood pressure later in life, new research suggests.
The amount of protein found in the urine during pregnancy may help identify those at greatest risk of developing long-term health problems.
Pre-eclampsia usually involves high blood pressure and increased protein in the urine. Some women also experience severe headaches and changes to their vision.
The condition cannot be treated during pregnancy and, in some cases, labour must be induced early to protect both the woman and baby.
The study found that the condition may be linked to longer-term health problems.
Anne Høy Seemann Vestergaard, a medical doctor and PhD at the department of clinical medicine at Aarhus University, said: “What we can see is a clear association between pre-eclampsia and the development of high blood pressure, chronic kidney disease and cardiovascular disease later in life.”
The researchers found that the amount of protein passed in the urine during pregnancy was linked to the risk of developing chronic conditions after giving birth.
Protein in the urine can indicate that the kidneys are not filtering blood normally.
Vestergaard said: “The most surprising finding was how clearly the amount of protein in the urine during pre-eclampsia was linked to the risk of later high blood pressure and chronic kidney disease. Women with moderate to severe protein excretion had a higher risk of both conditions compared with women with low or no protein excretion.”
Among women with pre-eclampsia and moderate to severe levels of protein in the urine, around one in 20 developed chronic kidney disease within 10 years and around one in six developed high blood pressure.
Most women in the study did not develop long-term complications, but the researchers said the increased risk should still be taken seriously because the potential effects can be severe.
Vestergaard said: “At first glance, this may sound like a low number, but it represents a markedly increased risk when the groups are compared. In the group with pre-eclampsia and high levels of protein in the urine, around 1 in 20 women developed chronic kidney disease within ten years, including early stages of the disease, compared with around 1 in 100 in the group with lower or no protein excretion.”
She added: “That is a considerable number in light of the fact that chronic kidney disease is a potentially serious condition that can progress to kidney failure if isn’t diagnosed early.”
The findings suggest women who experience pre-eclampsia may benefit from more systematic monitoring after pregnancy.
Vestergaard said: “Our study suggests that these women may benefit from monitoring of blood pressure and kidney function after pregnancy.”
Pregnancy
Pregnant women may reduce key health risk through more light exercise, study finds

Light exercise and less sitting may reduce pregnant women’s risk of serious blood pressure complications, according to a new study.
Researchers have proposed a daily activity and sleep guide that they say was linked to a nearly 30 per cent lower risk of hypertensive disorders of pregnancy.
The suggested pattern includes fewer than eight hours of sedentary time, at least seven hours of light physical activity, around 22 minutes of more intense activity and nearly nine hours of sleep.
The University of Iowa-led study examined the daily behaviours of 470 pregnant women across all stages of pregnancy.
Participants wore monitors that measured physical activity over 24-hour periods and recorded how long they spent asleep.
Hypertensive disorders of pregnancy include chronic high blood pressure, gestational hypertension and pre-eclampsia.
Gestational hypertension is high blood pressure that develops during pregnancy, while pre-eclampsia is a potentially serious condition involving high blood pressure and signs that organs may be affected.
Sedentary behaviour means being mostly inactive, such as sitting or lying down.
Light physical activity can include casual walking, moving around the home or standing.
Moderate to vigorous activity includes movement such as brisk walking, where breathing and heart rate increase.
Kara Whitaker, associate professor in the department of health, sport, and human physiology at Iowa and corresponding author of the study, said: “We are identifying the optimal composition of movement behaviours across the day associated with the lowest risk of developing HDP and the most improved health outcomes.
“This blueprint holds for each and every trimester of pregnancy.”
Study participants were enrolled at sites in Iowa City, Pittsburgh and Morgantown, West Virginia.
The women wore activity and sleep monitors for at least one week during each trimester of pregnancy.
Four in five participants were non-Hispanic white and nearly a quarter lived in rural areas.
The data showed a steep rise in risk among pregnant women who were sedentary for more than 10 hours a day.
Women who increased light physical activity to at least four hours a day reduced their risk of hypertensive disorders of pregnancy to 15 per cent from 30 per cent.
Whitaker said: “Just moving around more seems to have significant health benefits.
“And I think it also may be a more feasible target for women who are pregnant who are not exercising regularly.”
The researchers said they were surprised that longer durations of moderate to vigorous physical activity did not appear to provide additional benefit.
Sleep beyond a certain duration also did not appear to bring major further benefits.
Whitaker said: “Through this study, we are providing evidence that reducing sedentary behaviour and engaging in light physical activity are important, and maybe more important, when it comes to pregnancy and health.”
The findings may be relevant beyond pregnancy because clinical research has shown that women who develop hypertensive disorders of pregnancy are more than twice as likely to develop heart disease later in life.
Cardiovascular disease includes conditions affecting the heart and blood vessels, such as heart disease and stroke.
Whitaker said: “We know that cardiovascular disease is the number one killer of women, and if we can intervene in pregnancy and prevent women from developing a hypertensive disorder of pregnancy, we are putting them on a better trajectory, away from cardiovascular disease and toward more optimal cardiovascular health.”
The study was published online on June 10.
A second study, published online on May 27, looked more closely at the ratio and type of sedentary behaviour and light physical activity linked to a lower risk of hypertensive disorders of pregnancy.
Whitaker is a lead co-author on that study.
Co-authors in the June 10 study include Alex Crisp, Jaemyung Kim, Karina Smith, Donna Santillan, Mark Santillan and Bridget Zimmerman, from Iowa; Jacob Gallagher, from Iowa State University; Melissa Jones, from Oakland University in Michigan; Bethany Barone Gibbs, Katrina Wilhite, Alexis Thrower and Iqra Sheikh, from West Virginia University; and Sabera Rahman, Janet Catov, Christopher Kline and Maisa Feghali, from the University of Pittsburgh.
The National Institutes of Health, the University of Iowa Institute for Clinical and Translational Science, the University of Pittsburgh Clinical and Translational Science Institute and the West Virginia Clinical and Translational Science Institute funded the research.
Pregnancy
£50m initiative aims to tackle disparities in maternal healthcare
Menopause4 weeks agoPerimenopause misinformation ‘putting women at risk’
Entrepreneur4 weeks agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
News3 weeks agoWomen still being failed when they reach menopause, experts say
Insight2 weeks agoBritish women among angriest in Europe, health survey reveals
Menopause4 weeks agoSweden eyes domestic production of oestrogen patches amid menopause treatment shortage
News1 week agoFemtech World Awards 2026: Winners revealed
News3 weeks agoThree menopause innovators shortlisted for Femtech World Award
Menopause2 weeks agoApple Health adds menopause and perimenopause tracking
















1 Comment